NEW YORK (TheStreet) -- Shares of Reckitt Benckiser Group Plc (RBGLY) are lower -1.28% to $16.21 after the company said it's no longer in active talks to buy the consumer health unit of Merck & Co. (MRK - Get Report), saying the purchase doesn't meet its investment criteria, Bloomberg reports.

Bayer AG (BAYRY) is proposing a deal for the unit that could include some of the German company's health-care assets in addition to paying cash, sources told Bloomberg.

Must Read: Warren Buffett's 10 Favorite Growth Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

 RBGLY Chart

RBGLY data by YCharts

STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months.Learn more.